SHANGHAI, China, April 13 /Xinhua-PRNewswire/ -- The first "2007 Entrepreneurs on Innovation" forum was held on April 11, as scheduled, at the Shanghai Grand Hyatt Hotel. Corporate leaders and senior investors from all over China, as well as relevant leaders from Shenzhen Stock Exchange, gathered together to extensively discuss the topic of "Disruptive Innovation and Opportunities." The forum was both successful and fruitful, with a total of about 150 people attending.
Shanghai Highview Investment and Consultancy Co., Ltd organized this forum and specially invited GammaStar Medical Group, Wealink and Edushi, which were all selected in the Red Herring Asia 100. Representatives from invited companies shared their innovative paths and visions with all the attendants.
Experts from the Shenzhen Stock Exchange and representatives from IDG, Harbinger, GGV Bessemer, UCI, the Oxford Investment Group, UBS and Merrill Lynch, and so many others, reviewed and tracked corporate case studies, sharing their professional views thus giving attendees a view on the fast-developing hi-tech industry. The forum also highlighted potential investment projects among the attending companies.
The forum is seen as an important event since as all attendants are considered the kind of people who either start disruptive innovations or grab future opportunities. Although this is the first session of this forum, it is successful and rewarding and will bring in more high level discussions and cooperation, speeding up resource integration within China’s high-tech industry.
About GammaStar Medical Group
GammaStar Medical Group is a high-tech medical group company with world leading technology of its own proprietary rights in trauma treatment. It has been selected as one of the "RED HERRING 100" which is considered the "Silicon Valley Bible" and "Investment Vein," as well as one of the "Zero2ipo-China Venture50," thus becoming a company that has one of the best development potentials and investment value in Asia. With its headquarters based in Shanghai, it has established branches in several countries and is stretching its business across the world, and will supply comprehensive treatment to global trauma patients, thus fostering the best brand in trauma treatment.
It supplies the most advanced trauma treatment solutions to hospitals and patients by establishing trauma treatment centres around the world, and it also seeks to enter into neurosurgery and other medical fields. It focuses its business on the research and development of large medical equipment and clinic research, sales and services.
The Gyro Rotating Cobalt 60 Radiotherapy system is currently the most advanced precise radiotherapy machine in the world. Its unique "Gyro Peak" outperforms the "Brag Peak" of the proton system in terms of the dosage distribution and it autonomy level also outperforms the present world level in this industry. It has obvious competitive edges in the industry because it not only owns technology breakthroughs in mechanics and treatment but also creatively uses the business model of franchising. GMS will always hold the Company philosophy of "focusing on quality and caring for life."
The Company will keep developing better medical equipment and open a new age in trauma treatment with its advanced R&D and medical centre management abilities.
For more information, please contact:
Helen Yan
Tel: +86-21-5109-5758 x8036
Mobile: +86-137-9522-2598
Email: Helen@gammastar.com
